WHO Issues Supplement to Guidelines on Antiretroviral Drugs for Treating, Preventing HIV Infection

Article

The March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection provides complementary materials for the following chapters:

Chapter 5 – HIV diagnosis and ARV drugs for HIV prevention, including self-testing and early infant diagnosis

 Chapter 7 – Antiretroviral therapy, including optimizing ART for children and adults and the use of CD4 testing

Chapter 9 – Guidance on operations and service delivery, including rolling out viral load testing, procurement and supply chain management concerns and community models of ART delivery

Chapter 11 – Monitoring and evaluation, including surveillance of ARV drug toxicity monitoring and surveillance of drug resistance
 
The World Health Organization (WHO) will issue the next supplement to the consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection in the second half of 2014. This later supplement will include sections related to diagnosing and managing major opportunistic and other HIV-associated infections as well as on adherence and retention. Future supplements will address the interactions between HIV and noncommunicable diseases, mental health and nutrition.

Source: WHO

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.